SABBY MANAGEMENT, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 51 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$23,000
-95.9%
20,479
-93.3%
0.00%
-97.3%
Q1 2021$564,000
+216.9%
306,338
+434.5%
0.11%
+307.4%
Q3 2020$178,000
+39.1%
57,309
-21.0%
0.03%
-49.1%
Q1 2020$128,000
-54.0%
72,575
-36.9%
0.05%
-64.7%
Q3 2019$278,000115,0000.15%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders